Roland Jacobs

4.7k total citations · 1 hit paper
53 papers, 2.8k citations indexed

About

Roland Jacobs is a scholar working on Immunology, Genetics and Epidemiology. According to data from OpenAlex, Roland Jacobs has authored 53 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 11 papers in Genetics and 10 papers in Epidemiology. Recurrent topics in Roland Jacobs's work include Immune Cell Function and Interaction (17 papers), Immunodeficiency and Autoimmune Disorders (9 papers) and Mesenchymal stem cell research (7 papers). Roland Jacobs is often cited by papers focused on Immune Cell Function and Interaction (17 papers), Immunodeficiency and Autoimmune Disorders (9 papers) and Mesenchymal stem cell research (7 papers). Roland Jacobs collaborates with scholars based in Germany, Austria and United Kingdom. Roland Jacobs's co-authors include Ralf Hass, Cornelia Kasper, Stefanie Böhm, Reinhold E. Schmidt, Larry L. Butcher, Reinhold Schmidt, Nancy J. Woolf, Thomas Skripuletz, Debanjana Chatterjee and Dejene M. Tufa and has published in prestigious journals such as The Journal of Immunology, Brain Research and International Journal of Molecular Sciences.

In The Last Decade

Roland Jacobs

52 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC

2011 1.4k citations Ralf Hass, Cornelia Kasper et al. profile →

Peers

Countries citing papers authored by Roland Jacobs

Since Specialization

Citations

This map shows the geographic impact of Roland Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Jacobs more than expected).

Fields of papers citing papers by Roland Jacobs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Jacobs. The network helps show where Roland Jacobs may publish in the future.

Co-authorship network of co-authors of Roland Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Jacobs. A scholar is included among the top collaborators of Roland Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Jacobs. Roland Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rapid depletion of CD20+ B and T cells following ofatumumab therapy onset 2024 ·Multiple Sclerosis and Related Disorders ·Franz Felix Konen, Stefan Gingele, Martin W. Hümmert, Nora Möhn, (unknown), (unknown), Lea Grote‐Levi, Sandra Nay, Tabea Seeliger, (unknown), Konstantin Fritz Jendretzky, (unknown), Roland Jacobs, Thomas Skripuletz, Philipp Schwenkenbecher	1
2	PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy 2021 ·Therapeutic Advances in Neurological Disorders ·Nora Möhn, Mike P. Wattjes, Ortwin Adams, Sandra Nay, (unknown), (unknown), (unknown), Kaweh Pars, Günter U. Höglinger, Gesine Respondek, Martin Stangel, Thomas Skripuletz, Roland Jacobs, Kurt‐Wolfram Sühs	12
3	Peripheral Blood Lymphocyte Phenotype Differentiates Secondary Antibody Deficiency in Rheumatic Disease from Primary Antibody Deficiency 2020 ·Journal of Clinical Medicine ·Alexandra Dopfer‐Jablonka, (unknown), (unknown), Diana Ernst, Roland Jacobs, (unknown), Torsten Witte, Reinhold E. Schmidt, Faranaz Atschekzei, Georgios Sogkas	11
4	Late-Onset Antibody Deficiency Due to Monoallelic Alterations in NFKB1 2019 ·Frontiers in Immunology ·Claudia Schröder, Georgios Sogkas, Manfred Fliegauf, Thilo Dörk, Di Liu, Leif G. Hanitsch, Sophie Steiner, Carmen Scheibenbogen, Roland Jacobs, Bodo Grimbacher, Reinhold Schmidt, Faranaz Atschekzei	28
5	Role of CD20⁺ T cells in multiple sclerosis: implications for treatment with ocrelizumab 2019 ·Neural Regeneration Research ·Thomas Skripuletz, Stefan Gingele, Roland Jacobs	17
6	Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients 2018 ·Cells ·Stefan Gingele, (unknown), Franz Felix Konen, Martin W. Hümmert, Kurt‐Wolfram Sühs, Philipp Schwenkenbecher, Jonas Ahlbrecht, Nora Möhn, Lars Hendrik Müschen, Lena Bönig, Sascha Alvermann, Reinhold E. Schmidt, Martin Stangel, Roland Jacobs, Thomas Skripuletz	109
7	Chronic Granulomatous Disease First Diagnosed in Adulthood Presenting With Spinal Cord Infection 2018 ·Frontiers in Immunology ·Philipp Schwenkenbecher, Alexandra Neyazi, Frank Donnerstag, Felix C. Ringshausen, Roland Jacobs, Matthias Stoll, Paul A. Kirschner, Florian Länger, (unknown), Stefan Gingele, Florian Wegner, Kurt‐Wolfram Sühs, Martin Stangel, Thomas Skripuletz	7
8	Detection and quantification of rituximab in the human urine 2017 ·Journal of Immunological Methods ·Roland Jacobs, (unknown), (unknown), Klaus Stahl, Hermann Haller, Reinhold Schmidt, Mario Schiffer	41
9	The TLR-2/TLR-6 agonist macrophage-activating lipopeptide-2 augments human NK cell cytotoxicity when PGE2 production by monocytes is inhibited by a COX-2 blocker 2015 ·Cancer Immunology Immunotherapy ·(unknown), Dejene M. Tufa, Debanjana Chatterjee, Peter F. Mühlradt, Reinhold Schmidt, Roland Jacobs	14
10	NKG2C Deletion Is a Risk Factor of HIV Infection 2011 ·AIDS Research and Human Retroviruses ·Rachel Thomas, (unknown), Katja Kniesch, Roland Jacobs, Reinhold E. Schmidt, Torsten Witte	54
11	The Human Cytomegalovirus UL11 Protein Interacts with the Receptor Tyrosine Phosphatase CD45, Resulting in Functional Paralysis of T Cells 2011 ·PLoS Pathogens ·Ildar Gabaev, Lars Steinbrück, (unknown), Andreas Pich, Richard J. Stanton, Reinhard Schwinzer, Thomas F. Schulz, Roland Jacobs, Martin Messerle, (unknown)	50
12	Optimization of Culture Conditions for the Expansion of Umbilical Cord-Derived Mesenchymal Stem or Stromal Cell-Like Cells Using Xeno-Free Culture Conditions 2010 ·Tissue Engineering Part C Methods ·Tim Hatlapatka, Pierre Moretti, Antonina Lavrentieva, Ralf Hass, Nicole Marquardt, Roland Jacobs, Cornelia Kasper	55
13	Phenotyping of congenic dipeptidyl peptidase 4 (DP4) deficient Dark Agouti (DA) rats suggests involvement of DP4 in neuro-, endocrine, and immune functions 2009 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Nadine Frerker, Kerstin Raber, Felix J. Bode, Thomas Skripuletz, Heike Nave, Christian Klemann, Reinhard Pabst, Michael Stephan, J Schade, Georg Brabant, Dirk Wedekind, Roland Jacobs, Anne Jörns, Ulf Forssmann, Rainer H. Straub, (unknown), Torsten Hoffmann, Leona Wagner, Hans-Ulrich Demuth, Stephan von Hörsten	36
14	Altered Phenotype of NK Cells From Obese Rats Can Be Normalized by Transfer Into Lean Animals 2009 ·Obesity ·Anne Lautenbach, Christiane D. Wrann, Roland Jacobs, Günter Müller, Georg Brabant, Heike Nave	29
15	Postnatal Life Events Affect the Severity of Asthmatic Airway Inflammation in the Adult Rat 2008 ·The Journal of Immunology ·Carsten Kruschinski, Thomas Skripuletz, Sammy Bedoui, Kerstin Raber, Rainer H. Straub, Torsten Hoffmann, Karsten Grote, Roland Jacobs, Michael Stephan, Reinhard Pabst, Stephan von Hörsten	32
16	Adult onset of T-cell deficiency with impaired CD2 expression complicated by Rhodococcus infection: a case report 2007 ·Annals of Allergy Asthma & Immunology ·Jens M. Kittner, Roland Jacobs, (unknown), D. Peest, Matthias Stoll, Reinhold Schmidt	7
17	CD26 expression determines lung metastasis in mutant F344 rats: involvement of NK cell function and soluble CD26 2003 ·Cancer Immunology Immunotherapy ·Kiyoshi Shingū, (unknown), Margot Zielinska‐Skowronek, Dirk Meyer‐Olson, Roland Jacobs, Reinhold Schmidt, Rolf Mentlein, Reinhard Pabst, Stephan von Hörsten	34
18	Localization, transmission, spontaneous mutations, and variation of function of the Dpp4 (Dipeptidyl-peptidase IV; CD26) gene in rats 2003 ·Regulatory Peptides ·Tim Karl, (unknown), Dirk Wedekind, Hans J. Hedrich, Torsten Hoffmann, Roland Jacobs, Reinhard Pabst, Stephan von Hörsten	42
19	Expression and in-vivo modulation of α- and β-adrenoceptors on human natural killer (CD16+) cells 1997 ·Journal of Neuroimmunology ·(unknown), Robert J. Benschop, Roland Jacobs, A. Kemper, Reiner Oberbeck, Reinhold E. Schmidt, Manfred Schedlowski	93
20	The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's disease 1989 ·Neuroscience Letters ·Nancy J. Woolf, Roland Jacobs, Larry L. Butcher	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact